BeStock  
Markets › Compare › IBRX vs CORT

IBRX vs CORT

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
IBRX · ImmunityBio$6.02 ▼ 8.37%
CORT · Corcept Therapeutics$63.62 ▼ 2.09%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

12150289428567Nov 24, '25May 26, '26Nov 20, '26
  • IBRX +180.0%
  • CORT -18.1%

Head to head

MetricIBRXCORT
Price$6.02$63.62
Change today▼ 8.37%▼ 2.09%
Market cap$6.40B$6.96B
Return, 3 months-20.6%-48.4%
Return, year to date+204.0%+82.8%
Return, 1 year+189.4%-17.7%
P/E (TTM)–47.8
P/B-5.68.4
P/E percentile vs own 5y28th69th
Dividend yield––
Revenue growth (YoY, latest qtr)+52.3%+64.0%
Net profit growth (YoY)-174.3%+544.6%
Gross margin98.8%98.5%
Operating margin-150.2%11.5%
Net margin-607.8%16.5%
Return on equity–21.7%
Analyst target vs. price+136.7%+161.4%
Analyst buy share100%100%
RSI (14)3621
30-day volatility101.0%78.5%
Max drawdown, 1 year-48.2%-63.5%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CORT is the largest of the group by market value.
  • IBRX has returned the most over the past year.
  • CORT is growing revenue fastest.
  • CORT keeps the most profit per dollar of sales.
  • CORT has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top